Association of nasopharyngeal and laryngopharyngeal reflux with postnasal drip symptomatology in patients with and without rhinosinusitis

American Journal of Rhinology

Volumn 20, Issue 3, 2006, Pages 283-289

  Wise, Sarah K ^a   Wise, Justine C ^b   DelGaudio, John M ^a  

^a EMORY CLINIC   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOSENSOR; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; ENDOSCOPIC SURGERY; FEMALE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL REFLUX; NOSE DISEASE; NOSE SURGERY; PH; POSTNASAL DRIP; QUESTIONNAIRE; RHINOSINUSITIS; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; HYPOPHARYNX; MALE; MIDDLE AGED; NASOPHARYNGEAL DISEASES; PHARYNGEAL DISEASES; RHINITIS; SINUSITIS;

EID: 33746168730     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2006.20.2849     Document Type: Article

References (39)

1. Coffin LA. Response to: The relations of the upper air passages to diseases of the gastrointestinal tract. Ann Otol Rhinol Laryngol 12:521-526, 1903.
2. Koufman JA, Aviv JE, Casiano RR, et al. Laryngopharyngeal reflux: Position statement of the Committee on Speech, Voice, and Swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127:32-35, 2002.
3. Gaynor EB. Otolaryngologic manifestations of gastroesophageal reflux. Am J Gastroenterol 86:801-808, 1991.
4. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(suppl 53):1-78, 1991.
5. Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: Documentation with 24-hour ambulatory pH monitoring. Am J Gastroenterol 84:1503-1508, 1989.
6. Smit CF, van Leeuwen JAMJ, Mathus-Vliegen LMH, et al. Gastropharyngeal and gastroesophageal reflux in globus and hoarseness. Arch Otolaryngol Head Neck Surg 126:827-830, 2000.
7. Loughlin CJ, and Koufman JA. Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope 106: 1502-1505, 1996.
8. Maceri DR, and Zim S. Laryngospasm: An atypical manifestation of severe gastroesophageal reflux disease (GERD). Laryngoscope 111:1976-1979, 2001.
9. Little FB, Koufman JA, Kohut RI, et al. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 94:516-519, 1985.
10. Walner DL, Stern Y, Gerber ME, et al. Gastroesophageal reflux in patients with subglottic stenosis. Arch Otolaryngol Head Neck Surg 124:551-555, 1998.
11. Koufman JA, Amin MR, and Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 123:385-388, 2000.
12. Cohen JT, Bach KK, Postma GN, et al. Clinical manifestations of laryngopharyngeal reflux. Ear Nose Throat J 81(suppl 2):19-23, 2002.
13. Kuhn J, Toohill RJ, Ulualp SO, et al. Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 108:1146-1149, 1998.
14. Ulualp SO, Toohill RJ, and Shaker R. Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders. Otolaryngol Head Neck Surg 121:725-730, 1999.
15. Halstead LA. Role of gastroesophageal reflux in pediatric upper airway disorders. Otolaryngol Head Neck Surg 120: 208-214, 1999.
16. Kibblewhite DJ, and Morrison MD. A double-blind controlled study of the efficacy of cimetidine in the treatment of the cervical symptoms of gastroesophageal reflux. J Otolaryngol 19:103-109, 1990.
17. Lanza DC. Diagnosis of chronic rhinosinusitis. Ann Otol Rhinol Larygol 113(suppl 193):10-14, 2004.
18. Lanza DC, and Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117 (suppl):S1-S7, 1997.
19. Giacchi RJ, Sullivan D, and Rothstein SG. Compliance with anti-reflux therapy in patients with otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 110:19-22, 2000.
20. Belafsky PC, Postma GN, and Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 16:274-277, 2002.
21. DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope 115:946-957, 2005.
22. Piccirillo JF, Merritt MG, and Richards ML. Psychometric and clinimetric validity of the 20-item sino-nasal outcome test (SNOT-20). Otolaryngol Head Neck Surg 126:41-47, 2002.
23. Bilgen C, Ogut F, Kesimli-Dinc H, et al. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe pH monitoring in laryngopharyngeal reflux. J Laryngol Otol 117:386-390, 2003.
24. Johnson LF, and DeMeester TR. Twenty-four hour PH monitoring of the distal esophagus: A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325-332, 1974.
25. Smit CF, Tan J, Devriese PP, et al. Ambulatory pH monitoring at the upper esophageal sphincter. Laryngoscope 108: 299-302, 1998.
26. Vincent DA, Garrett JD, Radionoff SL, et al. The proximal probe in esophageal pH monitoring: Development of a normative database. J Voice 14:247-254, 2000.
27. Piper DW, and Fenton BH. PH stability and activity curves of pepsin with special reference to their clinical importance. Gut 6:506-508, 1965.
28. Panetti M, Pearson JP, Dettmar PW, et al. Active pepsin in airway secretions: Possible evidence for new supraesophageal pH criteria. Gastroenterology 120:A118-A119, 2001.
29. Dobhan R, and Castell DO. Normal and abnormal proximal esophageal acid exposure: Results of ambulatory dual-probe pH monitoring. Am J Gastroesterol 88:25-29, 1993.
30. Carrau RL, Khidr A, Crawley JA, et al. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 114:670-674, 2004.
31. Jacob P, Kahrilas PJ, and Herzon G. Proximal esophageal pH-metry in patients with "reflux laryngitis." Gastroenterology 100:305-310, 1991.
32. Vaezi MF, Schoeder PL, and Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 92:825-829, 1997.
33. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 109:1575-1582, 1995.
34. Noordzij JP, Khidr A, Desper E, et al. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 112:2192-2195, 2002.
35. Yorulmaz I, Ozlugedik S, and Kucuk B. Gastroesophageal reflux disease: Symptoms versus pH monitoring results. Otolaryngol Head Neck Surg 129:582-586, 2003.
36. Maldonado A, Diederich L, Castell DO, et al. Laryngopharyngeal reflux identified using a new catheter design: Defining normal values and excluding artifacts. Laryngoscope 113:349-355, 2003.
37. Postma GN, Belafsky PC, Aviv JE, et al. Laryngopharyngeal reflux testing. Ear Nose Throat J 81(suppl 2):14-18, 2002.
38. Johnson PE, Koufman JA, Nowak LJ, et al. Ambulatory 24-hour double-probe pH monitoring: The importance of manometry. Laryngoscope 111:1970-1975, 2001.
39. DelGaudio JM, and Waring JP. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 113: 598-601, 2003.